Skip to content

Author

Y. Kirichenco

We have 2 of 2 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Metabolomic phenotype of heart failure in cardio-oncology patients

Heart failure (HF) in cardio-oncology patients during anticancer therapy is usually regarded as an accelerated form of classical HF, which restricts early diagnosis and timely pathogenetically based treatment. Myocardial decompensation in these patients appears to involve distinct molecular mechanisms detectable...

R. Alieva, K. Fozilov, M. Yakhyoeva et al. · 0 citations
Open access Aug 2026

Early lipid profile deterioration during chemotherapy as a marker of subclinical vascular toxicity and therapy rationale

In patients with low and moderate baseline CV risk, a statistically significant deterioration in lipid profile was observed during chemotherapy, which is consistent with the development of subclinical endothelial dysfunction and early vascular toxicity, despite the absence of overt clinical manifestations of vasculotox...

R. Alieva, K. Fozilov, M. Yakhyoeva et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.